MENU
VRDN
AS OF
Nov 13 closing price
Price
$28.49
Change
-$0.45 (-1.55%)
Capitalization
2.72B
111 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viridian Therapeutics (VRDN) Earnings Date & Reports

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

VRDN is expected to report earnings to rise 205.88% to -103 cents per share on March 05

Viridian Therapeutics VRDN Stock Earnings Reports
Q4'25
Est.
$-1.04
Q3'25
Beat
by $0.61
Q2'25
Est.
$-1.00
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.22
The last earnings report on November 05 showed earnings per share of -34 cents, beating the estimate of -95 cents. With 1.59M shares outstanding, the current market capitalization sits at 2.72B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VRDN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRDN showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for VRDN
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com